×
About 13,365 results

ALLMedicine™ Ventricular Tachycardia Center

Research & Reviews  4,190 results

The monocyte to high-density lipoprotein cholesterol ratio is a risk factor for frequen...
https://doi.org/10.1186/s12944-022-01742-7
Lipids in Health and Disease; Wang Y, Li D et. al.

Dec 4th, 2022 - Little is known about the link between the monocyte to high-density lipoprotein cholesterol ratio (MHR) and frequent premature ventricular complexes (PVCs). This investigation aimed to evaluate the link between the MHR and frequent PVCs in patient...

Impact of wideband cardiac magnetic resonance on diagnosis, decision-making and outcome...
https://doi.org/10.1093/ehjci/jeac227
European Heart Journal. Cardiovascular Imaging; Patel HN, Wang S et. al.

Dec 3rd, 2022 - Although myocardial scar assessment using late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) imaging is frequently indicated for patients with implantable cardioverter defibrillators (ICDs), metal artefact can degrade image quality...

What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for...
https://doi.org/10.1093/ehjacc/zuac149
European Heart Journal. Acute Cardiovascular Care; Goette A, Lip GYH et. al.

Dec 1st, 2022 - The present paper summarizes and comments on the latest 2022 ESC guidelines on ventricular tachycardia and sudden cardiac death. Most relevant recommendations for acute cardiovascular care physicians are addressed, particularly, in the fields of c...

PREVENT-VT trial: game changer of ischemic ventricular tachycardia therapy?
https://doi.org/10.1007/s10840-022-01422-7
Journal of Interventional Cardiac Electrophysiology : an ... Casado-Arroyo R, Levinstein M

Nov 30th, 2022 - PREVENT-VT trial: game changer of ischemic ventricular tachycardia therapy?|2022|Casado-Arroyo R,Levinstein M,|

Advances in Cardiac Electrophysiology.
https://doi.org/10.1161/CIRCEP.121.009911
Circulation. Arrhythmia and Electrophysiology; Piccini JP, Russo AM et. al.

Nov 29th, 2022 - Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atr...

see more →

Guidelines  6 results

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 10th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement o...
https://doi.org/10.1016/j.cjca.2020.04.004
The Canadian Journal of Cardiology; Deyell MW, AbdelWahab A et. al.

Jun 17th, 2020 - This Canadian Cardiovascular Society position statement is focused on the management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that occurs in patients with structural heart disease (SHD), including previous myocar...

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324904
Circulation Panchal AR, Berg KM et. al.

Dec 21st, 2018 - Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes. This 2018 Ame...

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythm...
https://doi.org/10.1016/j.resuscitation.2018.11.018
Resuscitation Soar J, Perkins GD et. al.

Nov 30th, 2018 - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular ...

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447399
Neurology Geocadin RG, Wijdicks E et. al.

May 12th, 2017 - To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation. Published literature from 1966 to August 29, 2016, was...

see more →

Drugs  390 results see all →

Clinicaltrials.gov  334 results

Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]
https://clinicaltrials.gov/ct2/show/NCT03464019

Oct 14th, 2022 - NODE-301 is a two-part, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etripamil NS self-administered by patients who experience an episode of paroxysmal ventricular tachycardia (PSVT) in an...

Unpinning Termination Therapy for VT (US)
https://clinicaltrials.gov/ct2/show/NCT03093051

Oct 10th, 2022 - This non-blinded, single-arm open-label, phase 1 pilot, acute research feasibility trial aims to demonstrate that the safety and effectiveness of Unpinning Termination (UPT) electrotherapy observed in the canine can be translated to humans and to ...

Arrhythmia Detection After MI
https://clinicaltrials.gov/ct2/show/NCT05073419

Oct 10th, 2022 - Patients who have ventricular tachycardia or fibrillation at least 48 hours after an acute myocardial infarction (AMI) have a higher risk of sudden cardiac death. Current guidelines recommend that for primary prevention of sudden cardiac death, pa...

Noninvasive Cardiac Radioablation for Ventricular Tachycardia Refractory to Medication and Catheter Ablation
https://clinicaltrials.gov/ct2/show/NCT04757688

Oct 7th, 2022 - Ventricular tachycardia (VT) is a regular, rapid (faster than 100 beats per minute) abnormal heart rhythm resulting from aberrant electrical conduction in the ventricles of the heart. Coronary heart disease is responsible for the majority of VT ca...

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
https://clinicaltrials.gov/ct2/show/NCT03053141

Oct 7th, 2022 - The Rhythmia Mapping System is designed for electroanatomical mapping in catheter ablation procedures by optimizing the need for speed and accuracy. The system is able to simultaneously acquire data from multiple electrodes. In addition, based on ...

see more →

News  397 results

Morning vs Midday Exercise; LVADs and Cancer; Reperfusion Injury After Thrombectomy
https://www.medpagetoday.com/cardiology/prevention/101759

Nov 15th, 2022 - Is diabetes slipping in importance as a cardiovascular risk factor? (JAMA) Morning exercisers in the U.K. Biobank tended to have lower cardiovascular disease risk than those saving their physical activity for midday. (European Journal of Preventiv...

Oct 14, 2022 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/982394

Oct 14th, 2022 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

AF Detection by Smartwatch Challenging in Some Patients
https://www.medscape.com/viewarticle/982473

Oct 14th, 2022 - The ability of an Apple Watch to detect atrial fibrillation (AF) is significantly affected by underlying ECG abnormalities such as sinus node dysfunction, atrioventricular (AV) block, or intraventricular conduction delay (IVCD), a single-center st...

Video Games Trigger Dangerous Arrhythmias in Some Children
https://www.medscape.com/viewarticle/982197

Oct 11th, 2022 - Playing video games can produce potentially fatal arrhythmias in susceptible children, including those not known to be at risk, and war games are a potent trigger, an international case series and systematic review reveals. Nineteen patients exper...

Athletes With Mild HCM Can Likely Continue Competitive Sports
https://www.medscape.com/viewarticle/981782

Oct 3rd, 2022 - Athletes with mild hypertrophic cardiomyopathy (HCM) at low risk of sudden cardiac death (SCD) can safely continue to exercise at competitive levels, a retrospective study suggests. During a mean follow-up of 4.5 years, athletes who continued to e...

see more →

Patient Education  29 results see all →